Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: Main results of the RESPONSE randomised trial

Heart

Volumn 99, Issue 19, 2013, Pages 1421-1430

  Jorstad, Harald T ^a   Von Birgelen, Clemens ^b   Alings, A Marco W ^c   Liem, Anho ^d   Van Dantzig, Jan Melle ^e   Jaarsma, Wybren ^f   Lok, Dirk J A ^g   Kragten, Hans J A ^h   De Vries, Keesjan ⁱ   De Milliano, Paul A R ^j   Withagen, Adrie J A M ^k   Scholte Op Reimer, Wilma J M ^a   Tijssen, Jan G P ^a   Peters, Ron J G ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

^c AMPHIA HOSPITAL   (Netherlands)

^d Admiraal de Ruyter Hospital   (Netherlands)

^e CATHARINA HOSPITAL   (Netherlands)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g DEVENTER HOSPITAL   (Netherlands)

^h Sittard Geleen Heerlen   (Netherlands)

ⁱ MEDICAL CENTER LEEUWARDEN   (Netherlands)

^j Tergooi Hospitals   (Netherlands)

^k Reinier de Graaf Gasthuis ^*  (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FRUIT; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; INTERVENTION STUDY; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NURSE COORDINATED PREVENTION PROGRAMME; NURSING CARE; OUTPATIENT; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; VEGETABLE; WAIST CIRCUMFERENCE;

CORONARY ARTERY DISEASE;

ACUTE CORONARY SYNDROME; AGED; AMBULATORY CARE; CHI-SQUARE DISTRIBUTION; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NETHERLANDS; PATIENT EDUCATION AS TOPIC; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR; SECONDARY PREVENTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84883770851     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303989     Document Type: Article

References (17)

1. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-72. (Pubitemid 43947981)
2. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2003;10:S1-S10.
3. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
4. Murchie P, Campbell NC, Ritchie LD, et al. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ 2003;326:84.
5. Wood DA, Kotseva K, Connolly S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk ofcardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 2008;371:1999-2012. (Pubitemid 351799857)
6. Allen JK, Dennison CR. Randomized trials of nursing interventions for secondary prevention in patients with coronary artery disease and heart failure: systematic review. J Cardiovasc Nurs 2010;25:207-20.
7. Jørstad HT, Alings AMW, Liem AH, et al. RESPONSE study: Randomised Evaluation of Secondary Prevention by Outpatient Nurse SpEcialists: Study design, objectives and expected results. Neth Heart J 2009;17:322-8.
8. Braunholtz DA, Edwards SJ, Lilford RJ. Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". J Clin Epidemiol 2001;54:217-24. (Pubitemid 32162034)
9. Mccarney R, Warner J, Iliffe S, et al. The Hawthorne Effect: a randomised, controlled trial. BMC Med Res Methodol 2007;7:30.
10. Revalidatiecommissie Nederlandse Hartstichting/Nederlandse Vereniging voor Cardiologie. Richtlijn Hartrevalidatie. Den Haag: Nederlandse Hartstichting, 2004.
11. Burgers JS, Simoons ML, Hoes AW, et al. [Guideline 'Cardiovascular Risk Management']. Ned Tijdschr Geneeskd 2007;151:1068-74.
12. Conroy RM, Pyörälä K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003;24:987-1003. (Pubitemid 36712275)
13. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
14. Bhatt DL, Eagle KA, Ohman EM, et al. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010;304:1350-7.
15. D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J 2000;139(2 Pt 1):272-81. (Pubitemid 30090804)
16. Vernooij JWP, Kaasjager HAH, Van Der Graaf Y, et al. Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial. BMJ 2012;344:e3750.
17. Koopman C, Dis Iv, Bots M, et al. Hart- en vaatziekten in Nederland. In: Koopman C, van Dis I, Visseren FLJ, eds. Hart-en vaatziekten in Nederland 2012, cijfers over risicofactoren, ziekte en sterfte. Den Haag: Hartstichting, 2012:7-31.